Acquired by Teleflex
Industries BiotechnologyHealth CareMedical DeviceHeadquarters Regions Greater Boston Area, East Coast, New England Founded Date 2006 Founders Christopher Loose Operating Status Closed Last Funding Type Grant
Contact Email info@semprusbio.com Phone Number 6175777756
Semprus BioSciences is a venture-backed biomedical company headquartered in Cambridge, Massachusetts. Our innovative, multi-faceted Semprus technology signifies a breakthrough in medical device technology. Our current focus is to develop a vascular access catheter with the first single surface modification that is designed to simultaneously reduce
microbial adherence and thrombus accumulation over the life of the device. In December 2010, the company completed an $18 million Series B financing co-led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners (FMP), a national healthcare venture capital investment firm with a strategic relationship with Cleveland Clinic. Combined with previous financing rounds, Semprus has raised a total of $28.5 million in equity.
Transaction Name Semprus BioSciences acquired by TeleflexAcquired by TeleflexAnnounced Date Jun 25, 2012